...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: No mention of efficacy again...

"The "problem" here is that no one knows how Vascepa works."

In fairness, one could say the same of apabetalone. Both Vascepa and Apabetalone affect multiple cardioprotective pathways. Which one(s) are the pathways responsible for the MACE reduction for Vascepa or apabetalone? 

BearDownAZ

Share
New Message
Please login to post a reply